Suppression of AhR signaling pathway is associated with the down-regulation of UDP-glucuronosyltransferases during BBN-induced urinary bladder carcinogenesis in mice

Journal of Biochemistry

Volumn 147, Issue 3, 2010, Pages 353-360

  Iida, Katsuyuki ^a,b   Mimura, Junsei ^c   Itoh, Ken ^c   Ohyama, Chikara ^c   Fujii Kuriyama, Yoshiaki ^b   Shimazui, Toru ^a   Akaza, Hideyuki ^a   Yamamoto, Masayuki ^b,d  

^a Institute of Clinical Medicine   (South Korea)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

AhR; UDP glucuronosyltransferase; Urinary bladder carcinogenesis

Indexed keywords

AMINE; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A1; MESSENGER RNA; N NITROSOBUTYL (4 HYDROXYBUTYL) AMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; GENE TARGETING; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TIME;

ANIMALS; BUTYLHYDROXYBUTYLNITROSAMINE; CYTOCHROME P-450 CYP1A1; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCURONOSYLTRANSFERASE; HUMANS; MICE; RECEPTORS, ARYL HYDROCARBON; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; URINARY BLADDER NEOPLASMS;

MUS;

EID: 77249103551     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvp169     Document Type: Article

References (42)

1. Strassburg, C.P., Manns, M.P., and Tukey, R.H. (1997) Differential down-regulation of the UDPglucuronosyltransferase 1A locus is an early event in human liver and biliary cancer. Cancer Res. 57, 2979-2985
2. Strassburg, C.P., Nguyen, N., Manns, M.P., and Tukey, R.H. (1998) Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium. Mol. Pharmacol. 54, 647-654
3. Giuliani, L., Gazzaniga, P., Caporuscio, F., Ciotti, M., Frati, L., and Agliano, A.M. (2001) Can downregulation of UDP-glucuronosyltransferases in the urinary bladder tissue impact the risk of chemical carcinogenesis? Int. J. Cancer 91, 141-143
4. Giuliani, L., Ciotti, M., Stoppacciaro, A., Pasquini, A., Silvestri, I., De Matteis, A., Frati, L., and Aglianò , A.M. (2005) UDP- glucuronosyltransferases 1A expression in human urinary bladder and colon cancer by immunohistochemistry. Oncol. Rep. 13, 185-191
5. Nelson, C.P., Kidd, L.C., Sauvageot, J., Isaacs, W.B., De Marzo, A.M., Groopman, J.D., Nelson, W.G., and Kensler, T.W. (2001) Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]- pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1. Cancer Res. 61, 103-109
6. Dutton, G.J. (1980) Glucuronidation of Drugs and Other Compounds. CRC Press, Boca Raton, FL
7. Burchell, B. and Coughtrie, M.W. (1989) UDPglucuronosyltransferases. Pharmacol. Ther. 43, 261-289
8. Burchell, B., Nebert, D.W., Nelson, D.R., Bock, K.W., Iyanagi, T., Jansen, P.L., Lancet, D., Mulder, G.J., Chowdhury, J.R., Siest, G., Tephly, T.R., and Mackenzie, P.I. (1991) The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence. DNA Cell Biol. 10, 487-494
9. Vienneau, D.S., DeBoni, U., and Wells, P.G. (1995) Potential genoprotective role for UDPglucuronosyltransferases in chemical carcinogenesis: initiation of micronuclei by benzo(a)pyrene and benzo(e)- pyrene in UDP-glucuronosyltransferase-deficient cultured rat skin fibroblasts. Cancer Res. 55, 1045-1051
10. Kim, P.M., Winn, L.M., Parman, T., and Wells, P.G. (1997) UDP-glucuronosyltransferase-mediated protection against in vitro DNA oxidation and micronucleus formation initiated by phenytoin and its embryotoxic metabolite 5-(p-hydroxyphenyl)-5-phenylhydantoin. J. Pharmacol. Exp. Ther. 280, 200-209
11. Ciotti, M., Lakshmi, V.M., Basu, N., Davis, B.B., Owens, I.S., and Zenser, T.V. (1999) Glucuronidation of benzidine and its metabolites by cDNA-expressed human UDP-glucuronosyltransferases and pH stability of glucuronides. Carcinogenesis 20, 1963-1969
12. Filiadis, I. and Hrouda, D. (2000) Genetic factors in chemically-induced transitional cell bladder cancer. BJU Int. 86, 794-801
13. Tukey, R.H. and Strassburg, C.P. (2000) Human UDPglucuronosyltransferases: metabolism, expression, and disease. Annu. Rev. Pharmacol. Toxicol. 40, 581-616
14. Auyeung, D.J., Kessler, F.K., and Ritter, J.K. (2003) Differential regulation of alternate UDPglucuronosyltransferase 1A6 gene promoters by hepatic nuclear factor-1. Toxicol. Appl. Pharmacol. 191, 156-166
15. Lee, Y.H., Sauer, B., Johnson, P.F., and Gonzalez, F.J. (1997) Disruption of the c/ebp alpha gene in adult mouse liver. Mol. Cell. Biol. 17, 6014-6022
16. Chen, C., Staudinger, J.L., and Klaassen, C.D. (2003) Nuclear receptor, pregname X receptor, is required for induction of UDP-glucuronosyltranferases in mouse liver by pregnenolone-16 alpha-carbonitrile. Drug Metab. Dispos. 31, 908-915
17. Xie, W., Yeuh, M.F., Radominska-Pandya, A., Saini, S.P., Negishi, Y., Bottroff, B.S., Cabrera, G.Y., Tukey, R.H., and Evans, R.M. (2003) Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc. Natl Acad. Sci. USA 100, 4150-4155
18. Verreault, M., Senekeo-Effenberger, K., Trottier, J., Bonzo, J.A., Bélanger, J., Kaeding, J., Staels, B., Caron, P., Tukey, R.H., and Barbier, O. (2006) The liver X-receptor alpha controls hepatic expression of the human bile acid-glucuronidating UGT1A3 enzyme in human cells and transgenic mice. Hepatology 44, 368-378
19. Enomoto, A., Itoh, K., Nagayoshi, E., Haruta, J., Kimura, T., O'Connor, T., Harada, T., and Yamamoto, M. (2001) High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol. Sci. 59, 169-177
20. Auyeung, D.J., Kessler, F.K., and Ritter, J.K. (2003) Mechanism of rat UDP-glucuronosyltransferase 1A6 induction by oltipraz: evidence for a contribution of the Aryl hydrocarbon receptor pathway. Mol. Pharmacol. 63, 119-127
21. Perdew, G.H. (1988) Association of the Ah receptor with the 90-kDa heat shock protein. J. Biol. Chem. 263, 13802-13805
22. Pongratz, I., Mason, G.G., and Poellinger, L. (1992) Dual roles of the 90-kDa heat shock protein hsp90 in modulating functional activities of the dioxin receptor. Evidence that the dioxin receptor functionally belongs to a subclass of nuclear receptors which require hsp90 both for ligand binding activity and repression of intrinsic DNA binding activity. J. Biol. Chem. 267, 13728-13734
23. Metz, R.P. and Ritter, J.K. (1998) Transcriptional activation of the UDP-glucuronosyltransferase 1A7 gene in rat liver by aryl hydrocarbon receptor ligands and oltipraz. J. Biol. Chem. 273, 5607-5614
24. Fujisawa-Sehara, A., Sogawa, K., Yamane, M., and Fujii-Kuriyama, Y. (1987) Characterization of xenobiotic responsive elements upstream from the drugmetabolizing cytochrome P-450c gene: a similarity to glucocorticoid regulatory elements. Nucleic Acids Res. 15, 4179-4191
25. Nebert, D.W., Roe, A.L., Dieter, M.Z., Solis, W.A., Yang, Y., and Dalton, T.P. (2000) Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem. Pharmacol. 59, 65-85
26. Chen, S., Beaton, D., Nguyen, N., Senekeo- Effenberger, K., Brace-Sinnokrak, E., Argikar, U., Remmel, R.P., Trottier, J., Barbier, O., Ritter, J.K., and Tukey, R.H. (2005) Tissue-specific, inducible, and hormonal control of the human UDP-glucuronosyltransferase- 1 (UGT1) locus. J. Biol. Chem. 280, 37547-37557
27. Iida, K., Itoh, K., Kumagai, Y., Oyasu, R., Hattori, K., Kawai, K., Shimazui, T., Akaza, H., and Yamamoto, M. (2004) Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis. Cancer Res. 64, 6424-6431
28. Itoh, K., Chiba, T., Takahashi, S., ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., Yamamoto, M., and Nabeshima, Y. (1997) An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236, 313-322
29. Ito, N., Hiasa, Y., Tamai, A., Okajima, E., and Kitamura, H. (1969) Histogenesis of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)- nitrosamine in rats. Gann 60, 401-410
30. Bonfanti, M., Magagnotti, C., Bonati, M., Fanelli, R., and Airoldi, L. (1988) Pharmacokinetic profile and metabolism of N-nitrosobutyl-(4-hydroxybutyl) amine in rats. Cancer Res. 48, 3666-3669
31. Airoldi, L., Magagnotti, C., Bonfanti, M., and Fanelli, R. (1990) Alpha-oxidative metabolism of the bladder carcinogens N-nitrosobutyl(4- hydroxybutyl)- amine and N-nitrosobutyl(3-carboxypropyl)amine within the rat isolated bladder. Carcinogenesis 11, 1437-1440
32. Hashimoto, Y. and Kitagawa, H.S. (1974) In vitro neoplastic transformation of epithelial cells of rat urinary bladder by nitrosamines. Nature 252, 497-499
33. Mimura, J., Yamashita, K., Nakamura, K., Morita, M., Takagi, T.N., Nakao, K., Ema, M., Sogawa, K., Yasuda, M., Katsuki, M., and Fujii-Kuriyama, Y. (1997) Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells 2, 645-654
34. Adachi, J., Mori, Y., Matsui, S., Takigami, H., Fujino, J., Kitagawa, H., Miller, C.A. 3rd, Kato, T., Saeki, K., and Matsuda, T. (2001) Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J. Biol. Chem. 276, 31475-31478
35. Buckley, D.B. and Klaassen, C.D. (2009) Induction of mouse UDP-glucuronosyltransferase mRNA expression in liver and intestine by activators of aryl-hydrocarbon receptor, constitutive androstane receptor, pregnane X receptor, peroxisome proliferator-activated receptor alpha, and nuclear factor erythroid 2-related factor 2. Drug Metab. Dispos. 37, 847-856
36. Reisman, S.A., Yeager, R.L., Yamamoto, M., and Klaassen, C.D. (2009) Increased Nrf2 activation in livers from Keap1-knockdown mice increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen species. Toxicol. Sci. 108, 35-47
37. Pollenz, R.S. (2002) The mechanism of AH receptor protein down-regulation (degradation) and its impact on receptor-mediated gene regulation. Chemic-Biol. Interact. 141, 41-61
38. Pollenz, R.S. (2007) Specific blockage of ligand-induced degradation of the Ah receptor by proteasome but not calpain inhibitors in cell culture lines from different species. Biochem. Pharmacol. 74, 131-143
39. Salghetti, S.E., Muratani, M., Wijnen, H., Futcher, B., and Tansey, W.P. (2000) Functional overlap of sequences that activate transcription and signal ubiquitin- mediated proteolysis. Proc. Natl Acad. Sci. USA 97, 3118-3123
40. Muratani, M., Kung, C., Shokat, K.M., and Tansey, W.P. (2005) The F box protein Dsg1/Mdm30 is a transcriptional coactivator that stimulates Gal4 turnover and cotranscriptional mRNA processing. Cell 120, 887-899
41. Lipford, J.R., Smith, G.T., Chi, Y., and Deshaies, R.J. (2005) A putative stimulatory role for activator turnover in gene expression. Nature 438, 113-116
42. Chen, S., Operana, T., Bonzo, J., Nguyen, N., and Turkey, R.H. (2005) ERK kinase inhibition stabilizes the aryl hydrocarbon receptor. J. Biol. Chem. 280, 4350-4359